NORTH AMERICA SWABS COLLECTION KIT MARKET FORECAST 2023-2032

The North America swabs collection kit market growth analysis includes the assessment of the United States and Canada. As per the WHO, the number of COVID-19 cases in the US has reached 103 million as of July 2023. Consequently, there has been a significant upsurge in demand for swab collection kits owing to the increased testing capacity implemented in response. This expansion encompasses the establishment of testing facilities, mobile testing units, and at-home testing alternatives, all aimed at facilitating sample collection for testing. This augmented testing capacity has played a crucial role in the identification and isolation of individuals with the virus, as well as in tracking its transmission and implementing relevant public health measures.

The COVID-19 pandemic has also led to the expansion of diagnostic testing. The continued requirement for regular testing, particularly asymptomatic screening, has substantially driven up the demand for diagnostic tests. Efforts to enhance accessibility for the general public have contributed to this increased demand. Testing facilities are now available in various settings, including healthcare facilities, pharmacies, community centers, and drive-through locations. Additionally, the availability of at-home testing solutions has further eased testing barriers and led to a rise in the number of individuals seeking diagnostic tests. Such factors drive the United States swabs collection kit market growth.

The North America swabs collection kit market segmentation includes sample type, end-user, and tip material type. The end-user segment includes home healthcare, hospitals & clinics, diagnostic centers, and other end-users.

Swab collection kits play a pivotal role in hospitals and clinics. They serve multiple purposes, such as facilitating diagnostic testing, sample collection for laboratory analysis, and infection prevention measures. These comprehensive kits are equipped with all the necessary components to ensure safe and effective sample collection.

In the realm of infection control strategies, swab collection kits are indispensable tools. They empower healthcare providers to adhere to proper sample collection methods, thereby mitigating the risk of cross-contamination and the spread of infectious diseases. The inclusion of individually packaged, sterile swabs in these kits ensures aseptic procedures, effectively reducing the likelihood of contamination during sample collection.

Whereas in recent years, there has been a significant surge in demand for diagnostic testing, primarily driven by breakthroughs in testing technologies, increased awareness of the importance of early diagnosis, and the ongoing impact of the COVID-19 epidemic. Swab collection kits play a crucial role in this domain, as they are essential for gathering specimens for various diagnostic tests, including those for respiratory viruses, sexually transmitted illnesses, and bacterial infections. The rising testing requirements have prompted diagnostic centers to expand their use of swab collection kits.

Some of the eminent firms operating in the North America swabs collection kit market include Puritan Medical Products, Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Formlabs, etc.

Thermo Fisher Scientific Inc manufactures software, services, reagents & consumables, analytical instruments, and medical equipment for use in clinical, diagnostics, and research laboratories. It offers solutions for cellular biology & analysis, synthetic biology, and flow cytometry. Its product portfolio includes protein & molecular biology research technologies, electron microscopy, genetic sequencing, and mass spectrometry. The company distributes its services and products across Europe, Asia-Pacific, and the Americas and has its headquarters in Waltham, Massachusetts, in the United States.

One of its products, MicroTest Flocked Swab Kits, helps maintain organism viability and counts for repeat testing, quality control procedures, and verification studies.